General Information
Revision date
2019-07-01
Product name
Doxorubicin, Hydrochloride Salt
CAS No.
25316-40-9
Icons in SDS
Company Information
company name
LC Laboratories
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302+H312+H332
Hazard statements
Code
Statements
H302+H312+H332
Harmful if swallowed, in contact with skin or if inhaled
Section 2
Hazard statements
Toxic RTECS Substance category: Tumorigen; Drug; Mutagen; Natural Product; Human Data; Reproductive Effector May be harmful or fatal if inhaled, swallowed, or absorbed through skin Exposure may result in damage to the heart, skin, eyes, respiratory system, digestive system, endocrine system, and urinary system Ingestion may cause complete alopecia (hair loss), onycholysis (separation of nail from nail bed), nail bed hyperpigmentation, rash, itching, urticaria (hives), photosensitivity, acute nausea, vomiting, mucositis (inflammation and ulceration of the mucous membranes lining the digestive tract), anorexia, abdominal pain, dehydration, diarrhea, fever, chills, seizure and coma Exposure may cause tumors and adversely affect fertility and newborn and breastfed infants H302+312+332 - Harmful if swallowed, in contact with skin or if inhaled
Signal word
Danger
Precautionary statements
P2562 - Do not get in eyes, on skin or on clothing WARNING For Laboratory Research Use Only
